4.3. β-. Arrestin Assay

BB Beatriz Bueschbell
PM Prashiela Manga
EP Erika Penner
AS Anke C. Schiedel
request Request a Protocol
ask Ask a question
Favorite

The β-Arrestin recruitment assay system PathHunter® developed by DiscoverX (Fremont, CA, USA, https://www.discoverx.com/arrestin, accessed on 30 July 2021) detects GPCR activation following ligand stimulation. The assay is based on enzyme fragment complementation of β-galactosidase. The assay is performed using a cell line expressing an Enzyme Acceptor (EA) which is fused to the β-Arrestin. The second part of the enzyme (ProLink/ PL) is fused to the C terminus of the GPCR of interest. EA and PL are inactive as single fragments. When a ligand binds and activates the GPCR of interest, the β-arrestin-2 protein is recruited to the GPCR since it is involved in receptor desensitizing and recycling. The recruitment of the β-arrestin leads to the complementation of the β-galactosidase. The active enzyme can catalyze hydrolysis and generate chemiluminescence when an appropriate substrate is proved. Thus, measured chemiluminescence (or β-galactosidase activity) correlates with receptor activation. In this study, the recruitment assay was performed using engineered CHO cell lines stably expressing the β-Arrestin protein linked to the EA fragment. The cell lines were transfected with the GPCR cDNA of interest fused to the ProLink-tag.

At 48 h post-transfection, co-transfected CHO β-Arrestin DRD2 and DRD3 cells were seeded in 96 well-plates (NunclonTM F96 MicroWellTM, Thermo Fischer Scientific, Scwerte, Germany). On the day of the assay, the medium was changed for 90 µl of F12 with 100 U/mL penicillin G, 100 µg/mL streptomycin, and the cells were incubated for at least 2 h at 37 °C with 5% CO2. Then, 10 µl of DMSO-diluted dopamine was added. Unsupplemented F12 medium was used as negative control. The final dimethyl sulfoxide (DMSO) concentration per well was 1%. After 90 min, the PathHunter® detection reagent (DiscoverX, Fremont, CA, USA) was added to the cell plate (50 µL/well) and incubated 1 h at room temperature in the dark, and finally chemiluminescence was detected by using the MikroWin2000 software and a multimode microplate reader (Mithras LB 940, Berthold Technologies, Bad Wildbad, Germany).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A